Please see this link to read the JDRF International statement on the ongoing crisis in Ukraine.
Helping the diabetes community in Ukraine
Please see this link to read the JDRF International statement on the ongoing crisis in Ukraine.
Canada’s largest type 1 diabetes organization, formerly JDRF, urges federal partnership to establish a national network that would accelerate T1D cures and position Canada as a global hub for cell therapy clinical trials June 9, 2026 – Ottawa – Canada is at risk of missing a critical opportunity to lead the next breakthrough in type […]
This letter was authored by Breakthrough T1D Canada President and Chief Executive Officer Jessica Diniz. She is cosigning this letter with eight individuals working in health and research. It was published in Le Devoir on February 26, 2026. In Quebec, thousands of adults living with type 1 diabetes (T1D) face a persistent and unjustified inequity in access to […]
UPDATE: January 5, 2026 – Canada’s Drug Agency has just announced a decision not to reimburse Tzield (teplizumab) In Canada, reimbursement of therapeutics is based on recommendations from Canada’s Drug Agency (CDA) and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS). Applications for reimbursement review of Tzield (teplizumab) – the first disease-modifying […]
